Mesalamine
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5609 publications
Correction: Oral liposomal co-delivery of ultrasmall ceria and 5-aminosalicylic acid alleviates DSS colitis via ROS scavenging and microbiome remodeling.
Journal: Journal of materials chemistry. B
Published: October 29, 2026
Cutaneous leukocytoclastic vasculitis with concurrent colitis of uncertain aetiology.
Journal: BMJ case reports
Published: October 05, 2026
Real-World Epidemiology of Inflammatory Bowel Disease in Italy: Treatment Patterns, Adherence, and Costs in Patients with Ulcerative Colitis Treated with Mesalazine.
Journal: Drugs - real world outcomes
Published: September 29, 2026
Correction to "Mesalamine in Treatment of Intestinal Inflammatory Diseases-Formulation-Driven Strategies for Targeted Colonic Therapy and Remission Maintenance".
Journal: Drug development research
Published: September 28, 2026
Successful combination therapy with ustekinumab and intensive granulocyte and monocyte adsorptive apheresis in highly refractory pediatric ulcerative colitis: pathophysiological rationale and clinical outcome.
Journal: Immunological medicine
Published: September 24, 2026
Complex therapy of chronic bacterial prostatitis using the immunomodulatory drug sodium aminodihydrophthalazinedione
Journal: Urologiia (Moscow, Russia : 1999)
Published: September 15, 2026
When the Cure Turns Into a Culprit: Mesalamine and the Eosinophilic Lung.
Journal: Cureus
Published: September 12, 2026
Changing Prescription Patterns in Pharmacologically Treated Patients with Newly Diagnosed Inflammatory Bowel Disease in German Gastroenterology Practices: A Real-World Study, 2015-2024.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 12, 2026
Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.
Journal: Pakistan journal of pharmaceutical sciences
Published: September 08, 2026
Electrochemical sensing of 5-aminosalicylic acid via DES-based molecularly imprinted polymers/rGO: experimental and theoretical insights.
Journal: The Analyst
Published: August 27, 2026
Oral phytic acid-coordinated Prussian blue nanozymes reprogram the intestinal microenvironment for effective treatment of inflammatory bowel disease.
Journal: Journal of colloid and interface science
Published: August 25, 2026
Last Updated: 11/08/2026